Newark, NJ. September 9, 2022: Delphine Diagnostics’ CEO, Andy Bala, attended Manufacturing Briefing 2022 at NJIT and NJ Innovation Institute, both in Newark, NJ. The event was in-person and organized by BioNJ.
BioNJ, McKinsey, a few big pharma firms, and FDA came together to share forward-looking updates relevant to the BioPharma manufacturing space for the next two years.
The highlights of the event were presentations, Q&A sessions, networking, and a walkthrough of McKinsey’s Digital Capability Center- touted as a Digital AI/ML Capability Center – Demonstrated by McKinsey’s team, which was meant for Scientists/Technicians in manufacturing space to learn/hone the needed skills. Andy Bala said, “It was a wonderful event to hear about the manufacturing strategies for the near future and how we can adapt and accelerate along the way. It was also a great networking event, and we found prospective partners to manufacture our Sepsis Diagnostic Kit locally here in New Jersey. “
More info about BioNJ and its upcoming events can be found at the following link: https://bionj.org/
Delphine Diagnostics Inc Became An Inaugural Member Of The Sepsis Innovation Collaborative (sic)
Great news from the Delphine team!
Delphine Diagnostics accepted an invitation to join as an inaugural member of the Sepsis Innovation Collaborative (SIC) led by Sepsis Alliance. Delphine’s CEO, Andy Bala, stated that “we look forward to serving by volunteering our time and talents to provide the latest research and marketable products to clinicians and patients. Delphine’s research and development team is committed to providing high-quality data for research and analytical purposes produced by our daily operations.”
More info about SIC: https://lnkd.in/g5Gnipjz
Sepsis Innovation Collaborative (SIC) is a multi-stakeholder public/private collaborative launched by Sepsis Alliance that brings academic, clinical, industry, patient advocacy, reimbursement, research, and other stakeholders together with the common mission to address the challenges and unmet needs related to infection management and sepsis prevention, detection, treatment, and survivor support. SIC members:
- Facilitate public-private communication with U.S. government agencies on opportunities to accelerate innovation
- Develop a common sepsis lexicon
- Connect longitudinal sepsis patient and survivor data
- Improve equity across the infection management/sepsis continuum in underserved communities and vulnerable populations
- Accelerate the time-to-market of novel products and services
- Address the long-term healthcare challenges of sepsis survivors
#sepsisawareness #collaboration #delphinedx #healthcare #opportunities #innovation